entertainment -WSS

entertainment

author：explore 2025-08-19 12:15:28 - browse：98562

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Dark money group runs ads on China biotech bill

entertainment

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

The CDC's new social media misinformation war

A single Democrat is willing to weaken Medicare negotiation power

Updated Covid vaccine has 54% effectiveness, new study suggests

Addiction doctors spar with methadone clinics over legislation

entertainment

entertainment

Wikipedia

Hollywood unions extend contract negotiations for actors

AstraZeneca stays mum on Medicare drug pricing negotiations

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Adopting new red light myopia treatments may be short

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Surgery pushed Ben Carson to fame

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Insmed lung disease drug hits target in key Phase 3 trial

Moonlake's readout produced a cash windfall. Risks remain

The CDC's new social media misinformation war

explore

The Biogen Aduhelm mess could happen again

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Adam's Biotech Scorecard: Do Sarepta's exon

What will save rural psychiatry services? Higher Medicaid payments

Devoted Health’s losses in Medicare Advantage persist

Why CTE doesn’t keep Americans from enjoying the Super Bowl

hotspot

knowledge

entertainment

focus